SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-21-000013
Filing Date
2021-02-24
Accepted
2021-02-24 17:27:57
Documents
14
Period of Report
2021-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K supn-20210219.htm   iXBRL 8-K 45447
  Complete submission text file 0001356576-21-000013.txt   188080

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210219.xsd EX-101.SCH 2436
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20210219_cal.xml EX-101.CAL 722
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20210219_def.xml EX-101.DEF 1659
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210219_lab.xml EX-101.LAB 24274
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210219_pre.xml EX-101.PRE 12658
7 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210219_htm.xml XML 10780
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 21675036
SIC: 2834 Pharmaceutical Preparations